Theratechnologies (TSE:TH) Hits New 1-Year High – Should You Buy?

Theratechnologies Inc. (TSE:TH) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$3.13 and last traded at C$3.08, with a volume of 88466 shares traded. The stock had previously closed at C$2.91.

Theratechnologies Stock Up 2.4 %

The firm has a market cap of C$137.02 million, a PE ratio of -16.56, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The company has a 50-day simple moving average of C$2.04 and a 200-day simple moving average of C$1.90. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64.

Theratechnologies (TSE:TH) last posted its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 EPS for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The firm had revenue of C$30.96 million for the quarter. Analysts expect that Theratechnologies Inc. will post 0.0298643 earnings per share for the current fiscal year.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.